Hepatic Tumor - Pipeline Insight, 2017

Publisher Name :
Date: 28-Jul-2017
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's, "Hepatic Tumor-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Hepatic Tumor. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Hepatic Tumor by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight`s team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope of the report

  • The report provides a snapshot of the pipeline development for the Hepatic Tumor

  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Hepatic Tumor

  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information

  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Hepatic Tumor

  • The report also covers the dormant and discontinued pipeline projects related to the Hepatic Tumor

Reasons to Buy

  • Establish comprehensive understanding of the pipeline activity across this Hepatic Tumor to formulate effective R&D strategies

  • Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

  • Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine

  • Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Hepatic Tumor therapeutics

  • Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  • Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

Hepatic Tumor - Pipeline Insight, 2017

Table of Contents

1. Report Introduction

2. Hepatic Tumor Overview

3. Pipeline Therapeutics
An Overview of Pipeline Products for Hepatic Tumor

4. Comparative Analysis

5. Products in Clinical Stage
5.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities

6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities

7. Therapeutic Assessment
Assessment by Route of Administration
Assessment by Stage and Route of Administration
Assessment by Molecule Type
Assessment by Stage and Molecule Type

8. Inactive Products
8.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1:Total Products for Hepatic Tumor
Table 2: Products in Clinical Stage
Table 3: Products in Pre-Clinical and Discovery Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products

List of Figures

Figure 1:Total Products for Hepatic Tumor
Figure 2: Products in Clinical Stage
Figure 3: Products in Pre-Clinical and Discovery Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products
  • Global Cancer Immunotherapy Market Analysis & Forecast to 2022 Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT) & IDO Inhibitors
    Published: 23-Oct-2017        Price: US 4900 Onwards        Pages: 370
    Within the cancer therapeutics space, which today is worth over $100 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that have high specificity for cancer cells. Today, cancer immunotherapy drugs have captured nearly 50% of the overall oncology drugs market, generating about $54 billion in 2016 alone and are forecast to surpass $100 billion in 2022. This report describes the evolution of such a huge market in 20 chapte......
  • Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 254
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2017, provides an overview of the Human Papillomavirus (HPV) Associated Cancer (Oncology) pipeline landscape.Human papillomavirus (HPV) is the most common viral infection of the reproductive tract. Human papillomavirus (HPV) has been found to be associated with several types of cancer. Risk factors include smoking, weakened immune system, long-......
  • Peritoneal Cancer - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 876
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritoneal Cancer - Pipeline Review, H2 2017, provides an overview of the Peritoneal Cancer (Oncology) pipeline landscape.Peritoneal cancer is a rare cancer that develops in the peritoneum, a thin, delicate sheet that lines the inside wall of the abdomen and covers the uterus and extends over the bladder and rectum. Peritoneal cancer usually manifests with abdominal distention and diffuse nonspecific abdominal......
  • Rhabdomyosarcoma - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 226
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rhabdomyosarcoma - Pipeline Review, H2 2017, provides an overview of the Rhabdomyosarcoma (Oncology) pipeline landscape.Rhabdomyosarcoma (RMS) is a malignant tumor of connective tissue in which abnormal cells are thought to arise from primitive muscle cells. Symptoms include pain, fever, purplish discoloration of the eye, hearing loss, headaches, bulging of the eye, or a droopy eyelid and tingling or weakness.......
  • Fallopian Tube Cancer - Pipeline Review, H2 2017
    Published: 10-Oct-2017        Price: US 2000 Onwards        Pages: 875
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fallopian Tube Cancer - Pipeline Review, H2 2017, provides an overview of the Fallopian Tube Cancer (Oncology) pipeline landscape.Fallopian tube cancer is also called tubal cancer. It develops in the fallopian tubes, which serve as a connection between the ovaries and the uterus. It occurs very rarely. The common symptoms of fallopian tube cancer may include abnormal vaginal bleeding, especially after menopaus......
  • Global Kaposi Sarcoma Market Size, Status and Forecast 2022
    Published: 06-Oct-2017        Price: US 3300 Onwards        Pages: 98
    This report studies the global Kaposi Sarcoma market, analyzes and researches the Kaposi Sarcoma development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Merck - Pfizer - Johnson & Johnson - GlaxoSmithKline - Bristol-Myers Squibb - Eli Lilly Market segment by Regions/Countries, this report covers - United States - EU - ......
  • Oligodendroglioma - Pipeline Review, H2 2017
    Published: 30-Sep-2017        Price: US 2000 Onwards        Pages: 148
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Oligodendroglioma - Pipeline Review, H2 2017, provides an overview of the Oligodendroglioma (Oncology) pipeline landscape.Oligodendroglioma is a type of glioma (primary glial brain tumor). They often contain mineral deposits (called calcifications), areas of hemorrhage, and/or cysts. The most common symptoms are seizures, headaches, and personality changes. Other symptoms vary by location and size of the tumor......
  • Esophageal Cancer - Pipeline Review, H2 2017
    Published: 30-Sep-2017        Price: US 2000 Onwards        Pages: 591
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Esophageal Cancer - Pipeline Review, H2 2017, provides an overview of the Esophageal Cancer (Oncology) pipeline landscape.Esophageal cancer is cancer that occurs in the esophagus. Symptoms include cough, difficulty swallowing, chest pain, pressure or burning and weight loss. Predisposing factors include age, smoking, obesity and bile reflux. Treatment includes chemotherapy, radiation therapy and surgery.......
  • Global Cancer Supportive Care Market 2017-2021
    Published: 21-Sep-2017        Price: US 3500 Onwards        Pages: 96
    Cancer supportive care drugs are used for the treatment of adverse effects caused due to the cancer treatment such as chemotherapy-induced anemia, CINV, bone metastasis, cancer pain, and others. Various class of drugs are used as cancer supportive care drugs. Some of the major drug class that involves in cancer supportive care are antiemetic drugs, erythropoietin-stimulating agents, granulocyte-stimulating agents, analgesics, and others. The analysts forecast global cancer supportive ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs